If you look closely at the fundamental discoveries that have changed human health, physician–scientists have been at the ...

Knocking out a single gene reprograms part of the large intestine to function like the nutrient-absorbing small intestine.

Sangamo Therapeutics has stacked up $18 million cash from Eli Lilly in a licensing deal that will let the pharma use the ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved ...

Governor Gavin Newsom announced March 21 that the Department of Health Care Services submitted an application to the federal Center for Medicaid and Medicaid Innovation at the Centers for Medicare & ...

The layoffs at the gene therapy company are part of restructuring of Spark Therapeutics by its owner, Roche Group.

Maria Lowe, Ph.D., associate vice president of Pharmaceutical Intelligence at Institute for Clinical and Economic Review ...

GreenLight Biosciences, Inc., a Boston-based agtech company with lab, office and greenhouse space in RTP, has closed a Series C funding round, including a $25 million investment from a new investor, ...

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $40.1 billion by 2034, creating some tremendous long-term opportunities for investors. Here are seven of ...

In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a "master regulator" ...

Knocking out a single gene reprograms part of the large intestine to function like the nutrient-absorbing small intestine. In ...

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.